My research over the last 20 years has evaluated the ability of therapeutics to regenerate injured tissue and product development. My focus is on preclinical modeling and safety evaluation as well as interactions with the FDA and translating novel concepts to treat unmet medical needs. As a board certified toxicologist, I am excited to participate in the development of a product to reduce chronic alcohol use. I look forward to participating in insuring the safe use of IVM in this therapeutic arena.
